BMC Medicine AI Policy: ChatGPT and Generative AI Disclosure Rules for BMC Medicine Authors
BMC Medicine requires AI disclosure under Springer Nature rules. AI cannot be an author. This guide covers where to disclose, what to disclose, and the consequences of non-compliance for BMC Medicine submissions.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
BMC Medicine at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 8.8 puts BMC Medicine in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~20% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: BMC Medicine takes ~30-45 days. A faster-turnaround journal may suit a grant or job deadline better.
- If OA is required: gold OA costs ~$3,500 USD. Check institutional agreements before submitting.
Quick answer: The BMC Medicine AI policy follows Springer Nature's rules calibrated to clinical research with population-level relevance and methodological transparency submissions. AI tools can be used for manuscript preparation but every use must be disclosed in the Methods section, with BMC Medicine's editorial team checking specifics at desk-screen. AI cannot be listed as an author of any BMC Medicine paper. AI-generated figures and schematics representing original research data are prohibited under BMC Medicine's image-integrity standard. BMC Medicine editors treat undisclosed use as a publication-ethics violation per ICMJE + COPE.
Run the BMC Medicine submission readiness check which includes an automated AI-disclosure audit, or work through this guide manually. Need broader context? See the BMC Medicine journal overview.
The Manusights BMC Medicine readiness scan. This guide tells you what BMC Medicine's editors look for when verifying AI disclosure at desk-screen. The scan tells you whether YOUR Methods section has the required language before you submit. We have reviewed manuscripts targeting BMC Medicine and peer venues; the named patterns below are the same ones Lin Lee leads BMC Medicine triage; Editor-in-Chief and Springer Nature's editorial AI working group flag at the desk-screen and editorial-board consultation stages. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.
Editorial detail (for desk-screen calibration). Chief Editor: Lin Lee leads BMC Medicine editorial decisions. Editorial-board listings change; verify the current incumbent at the journal's editorial-team page before quoting the name in a submission cover letter. Submission portal: https://www.editorialmanager.com/bmcmed/. Manuscript constraints: 350-word abstract limit and 5,000-word main-text cap (BMC Medicine flexible cap with editor approval). We reviewed Springer Nature's AI policy framework against current BMC Medicine author guidelines (accessed 2026-05-08); evidence basis includes both publicly documented Springer Nature policy and our internal anonymized submission corpus. The applicable word limit at BMC Medicine is shown below: 350-word abstract limit and 5,000-word main-text cap (BMC Medicine flexible cap with editor approval).
Verify exact word and figure limits against the latest author guidelines before submission. The named editorial-culture quirk: BMC Medicine reviewers consistently flag CONSORT/PRISMA checklist incompleteness as a delay driver.
What does BMC Medicine's AI policy require?
BMC Medicine authors must follow four rules under Springer Nature's AI framework, all enforced at desk-screen:
Rule 1: Disclose every AI tool used in manuscript preparation
Authors must name every generative AI tool used, its version, and how it was used. The disclosure goes in the Methods section, not the Acknowledgments. Examples that REQUIRE disclosure at BMC Medicine:
- For BMC Medicine-targeted manuscripts addressing clinical research with population-level relevance and methodological transparency: using ChatGPT, Claude, Gemini, or similar to draft, polish, or edit manuscript text passing through BMC Medicine editorial review
- For BMC Medicine submissions: using AI to generate boilerplate text for limitations, ethics statements, or BMC Medicine-specific response-to-reviewers letters that cite Springer Nature's framework
- For BMC Medicine submissions: using AI to translate manuscript text into English from another language, with Springer Nature expecting disclosure of the source language and translation chain
- For BMC Medicine literature reviews: using AI for citation discovery or summarizing prior BMC Medicine work; Springer Nature's policy applies regardless of citation context
- For BMC Medicine analytical pipelines: AI-assisted code generation requires Methods + code disclosure under ICMJE + COPE, particularly when code touches clinical research with population-level relevance and methodological transparency analysis
Examples that do NOT require AI disclosure:
- At BMC Medicine, using grammar/spell checkers (Word, Grammarly basic) that do not generate new content for the manuscript
- For BMC Medicine submissions, using reference managers (Zotero, EndNote) for citation formatting against Springer Nature's style guide
- For BMC Medicine statistical analysis, using established statistical software (R, Stata, SPSS) where the algorithm is the established tool documented in BMC Medicine's methodological norm, not a generative AI
Rule 2: AI cannot be an author
No AI tool can be listed as an author of a BMC Medicine paper, particularly for clinical research with population-level relevance and methodological transparency-class submissions. Under Springer Nature's policy: authorship requires the ability to take responsibility for the content, agree to be accountable for accuracy, and to consent to publication. AI tools cannot do any of these in BMC Medicine's editorial framework. This rule is consistent across all Springer Nature-published journals and applied at BMC Medicine's desk-screen.
Rule 3: AI-generated figures are prohibited for original research data
BMC Medicine editorial team does not accept AI-generated images, figures, or schematics that represent original research data in clinical research with population-level relevance and methodological transparency-class submissions. AI tools may assist with figure layout (axis labeling, color schemes) but the underlying data visualization must come from the actual research. AI-generated diagrams used for conceptual illustrations (e.g., a schematic of a hypothesized mechanism) require explicit disclosure and a statement that the diagram is conceptual.
Rule 4: Disclose AI use in peer review participation
Reviewers writing reports for BMC Medicine cannot use generative AI to draft their reports without disclosing it to the editor. Some Springer Nature journals prohibit AI-assisted reviewing entirely; BMC Medicine follows Springer Nature's default of disclosure-required. The editor decides whether the report is acceptable based on disclosure.
How does BMC Medicine's AI policy compare to peer journals?
Rule | BMC Medicine stance | Springer Nature default | ICMJE/COPE alignment |
|---|---|---|---|
AI authorship | Prohibited | Prohibited | ICMJE-aligned |
Disclosure location | Methods section | Methods section | ICMJE-aligned |
AI-generated figures | Prohibited for original data | Prohibited | COPE image-integrity-aligned |
Reviewer AI use | Disclosure required | Disclosure required | COPE peer-review-aligned |
Enforcement intensity | Desk-screen check | Desk-screen check | Pre-publication enforcement |
Source: https://www.springernature.com/gp/policies/ethics-policies/ai-policies (accessed 2026-05-08) plus BMC Medicine author guidelines.
What does AI disclosure look like in a BMC Medicine Methods section?
Acceptable disclosure language for BMC Medicine submissions:
"For our clinical research with population-level relevance and methodological transparency-focused manuscript at BMC Medicine, we used ChatGPT-4o (OpenAI, version dated October 2024) to polish English-language phrasing in the Introduction and Discussion sections. We did not use generative AI for data analysis, figure generation, or substantive manuscript content. All authors reviewed and edited the AI-assisted text and take responsibility for the final manuscript."
Or, for AI-assisted code:
"For this BMC Medicine submission addressing clinical research with population-level relevance and methodological transparency, initial Python code for the Bayesian regression analysis was drafted with Claude 3.5 Sonnet (Anthropic, version dated December 2024). All code was reviewed, modified, and validated by the authors before use; the final version is available at [repository URL]. Statistical inference was performed using the established R package brms."
What does NOT pass BMC Medicine's desk-screen:
- For BMC Medicine addressing clinical research with population-level relevance and methodological transparency: "AI tools were used in manuscript preparation." Too vague for Springer Nature editorial review of BMC Medicine submissions; the BMC Medicine editorial team needs the specific tool name, version, and specific use case
- "We acknowledge AI assistance in the Acknowledgments." (Wrong location; must be Methods)
- "ChatGPT helped write this paper." (Insufficient detail on use case)
- No disclosure when AI was used (publication-ethics violation)
What do pre-submission reviews reveal about BMC Medicine's AI-disclosure desk-screen failures?
In our pre-submission review work on BMC Medicine-targeted manuscripts, three patterns most consistently predict AI-policy desk-screen flags at BMC Medicine. Of the manuscripts we screened in 2025 targeting BMC Medicine and peer venues, the patterns below are the same ones Springer Nature's editorial AI working group flags during editorial review.
AI disclosure missing despite obvious AI-assisted phrasing. BMC Medicine editors identify AI-drafted text by patterns like overuse of em-dashes, formulaic transitions ("In conclusion," "Furthermore"), and uniform sentence length variance. When the manuscript shows these patterns but contains no AI disclosure, it triggers an editorial query. Check whether your manuscript reads as AI-assisted
AI disclosure in Acknowledgments instead of Methods. BMC Medicine editorial team flags this as a common mistake against clinical research with population-level relevance and methodological transparency submissions. Springer Nature's policy specifies Methods placement so that the disclosure is part of the methodological record, not a courtesy under BMC Medicine's editorial culture. Misplaced disclosures get flagged at desk-screen and require resubmission. Check whether your AI disclosure is in the right section
Generic disclosure language without tool name and version. BMC Medicine editorial team requires the specific tool, its version (or access date), and the specific use case. "AI tools were used" without specifics gets returned. Check whether your AI disclosure has the required specificity
What is the BMC Medicine AI-policy compliance timeline?
Stage | Duration | What happens |
|---|---|---|
Author drafts AI disclosure | 30-60 minutes | Identify all AI use, gather tool versions, write Methods paragraph |
Co-author review of disclosure | 1-2 days | All authors confirm the disclosure is complete and accurate |
Editorial desk-screen check | 1-2 weeks | BMC Medicine's editorial team verifies disclosure against the manuscript |
Editorial query (if disclosure incomplete) | 5-10 days | Editor requests revision before sending to peer review |
Reviewer AI-disclosure check | During peer review | Reviewers verify the disclosure matches the manuscript style |
Source: Manusights internal review of BMC Medicine-targeted submissions, 2025 cohort.
Submit If
- For BMC Medicine submissions on clinical research with population-level relevance and methodological transparency: the manuscript explicitly discloses every AI tool used, with name, version, and specific use case in the Methods section, calibrated to BMC Medicine's editorial expectations
- For BMC Medicine: no AI tool is listed as an author; all listed authors meet ICMJE authorship criteria, agree to take responsibility, and Springer Nature expects this acknowledgment in the cover letter
- For BMC Medicine: figures and schematics representing original research data come from the actual research, not AI generation, with BMC Medicine editorial team checking image-integrity at desk-screen
- For BMC Medicine submissions: the disclosure includes a statement that all human authors reviewed and edited the AI-assisted text, with Springer Nature requiring this acknowledgment per ICMJE + COPE
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Think Twice If
- The manuscript shows AI-drafted text patterns (em-dash overuse, formulaic transitions) but contains no AI disclosure; BMC Medicine desk-screen will flag this.
- The AI disclosure is in the Acknowledgments instead of the Methods section, against Springer Nature's explicit guidance.
- The disclosure language is generic ("AI tools were used") without specifying tool name, version, and use case; BMC Medicine editors return manuscripts with this gap.
- Any figure or schematic representing original research data was generated by AI; BMC Medicine prohibits this regardless of disclosure.
Manusights submission-corpus signal for BMC Medicine. Of the manuscripts our team screened before submission to BMC Medicine and peer venues in 2025, the AI-policy compliance gap most consistent across the cohort is generic disclosure language without tool-version specificity. In our analysis of anonymized BMC Medicine-targeted submissions, manuscripts with complete AI disclosure (tool name, version, specific use case, all-author confirmation) clear desk-screen at the same rate as manuscripts without AI use; manuscripts with incomplete or missing disclosure trigger editorial queries that add 1-2 weeks to the timeline. Springer Nature's editorial AI working group reviews disclosures against ICMJE + COPE framework requirements, and BMC Medicine applies that framework consistently with Springer Nature's broader policy. Recent retractions in the BMC Medicine corpus include 10.1186/s12916-022-02401-5, 10.1186/s12916-021-02110-5, and 10.1186/s12916-023-02901-y. Citing any of these without acknowledging the retraction is an automatic publication-ethics flag, separate from AI-disclosure issues.
What can BMC Medicine authors do to stay ahead of AI policy changes?
Springer Nature's AI policy framework continues to evolve as 2026 brings new ICMJE recommendations, COPE guidance refinements, and journal-specific clarifications. BMC Medicine authors targeting clinical research with population-level relevance and methodological transparency submissions should track three signals throughout 2026:
Quarterly policy updates from Springer Nature. Springer Nature's editorial AI working group reviews the AI framework on a rolling basis. BMC Medicine authors who pre-register their disclosure language at submission time tend to face fewer revisions during the 2026 transition period than authors who write boilerplate disclosures.
Field-specific clarifications for clinical research with population-level relevance and methodological transparency. Different research domains see different AI use patterns. BMC Medicine's editorial team has been refining what counts as "substantive AI use" versus "ancillary AI assistance" for clinical research with population-level relevance and methodological transparency work. Authors who err on the side of more disclosure rather than less avoid the publication-ethics gray zone.
Reviewer disclosure norms. As Springer Nature extends AI-disclosure rules to peer reviewers, the response rate from BMC Medicine reviewers may shift. Authors should expect that BMC Medicine reviewers' use of AI tools is now also disclosed and factored into editorial decisions.
- Manusights internal preview corpus (150+ BMC Medicine-targeted manuscripts, 2025 cohort)
Frequently asked questions
Yes, with mandatory disclosure. BMC Medicine follows Springer Nature's AI policy under the ICMJE + COPE framework. AI tools can be used for language editing, manuscript preparation, and analysis support, but all use must be disclosed in the Methods section. AI cannot be listed as an author, and human authors bear full responsibility for the content.
In the Methods section. Authors must name the specific AI tool (e.g., ChatGPT-4o, Claude 3.5 Sonnet), its version, and describe how it was used. The disclosure should confirm that all human authors reviewed and take responsibility for the AI-assisted content. BMC Medicine's editorial team checks this disclosure during desk-screen.
No. BMC Medicine prohibits AI-generated figures, schematics, and images intended to represent original research data. AI tools may assist with figure layout and labeling, but the underlying data and visualizations must come from the actual research. This rule is part of Springer Nature's broader image-integrity policy.
BMC Medicine treats undisclosed AI use as a publication-ethics violation following COPE guidelines. Consequences range from required correction to expression of concern or retraction, depending on severity. Springer Nature may notify the authors' institution in serious cases.
The core requirements (disclosure in Methods, no AI authorship, no AI-generated figures) are consistent across Springer Nature-published journals. BMC Medicine applies these rules consistently with Springer Nature's broader policy framework. The journal-specific element is enforcement intensity at desk-screen, which at BMC Medicine is calibrated by bmc medicine reviewers consistently flag consort/prisma checklist incompleteness as a delay driver.
Sources
- Springer Nature AI policy (accessed 2026-05-08)
- BMC Medicine author guidelines (accessed 2026-05-08)
- ICMJE recommendations on AI use (accessed 2026-05-08)
- COPE guidance on AI in research publication (accessed 2026-05-08)
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- BioMedCentral Submissions: BMC Medicine Guide
- how to avoid desk rejection at BMC Medicine
- Is BMC Medicine a Good Journal? The Open-Access General Medicine Option
- BMC Medicine Acceptance Rate (2026): What the ~12% Number Actually Means
- BMC Medicine APC and Open Access: Pricing, Waivers, Transformative Agreements (2026)
- BMC Medicine Pre Submission Checklist: 12 Items Editors Verify Before Peer Review
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.